1
|
Siddiqui R, Khan NA. Locusts: A Model to Investigate Human Disease and Sickness Behavior. ACS Pharmacol Transl Sci 2020; 3:1423-1424. [PMID: 33344911 DOI: 10.1021/acsptsci.0c00151] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2020] [Indexed: 11/29/2022]
Abstract
Traditionally, vertebrate models have been utilized and are viewed as more pertinent; however, we propose the application of an invertebrate model such as locusts to study human disease and sickness behavior at an early phase of research. This model has numerous benefits, namely, expense, swiftness, procedural convenience, and ethical acceptance. For example, the injection of immunogen-induced anorexia behavior in rats and locusts in vivo are analogous. Moreover, the presence of a brain barrier in locusts reveals remarkable similarities in molecular methods utilized by E. coli K1 to traverse the central nervous system of rats and locusts, consequently providing a worthwhile model to investigate pathogenesis. The presence of cytokines in these insects and presence of a brain barrier (which is physiologically relevant to human blood-brain barrier) makes it a relevant model in determining disease mechanisms and invasion of the brain by central nervous system pathogens.
Collapse
Affiliation(s)
- Ruqaiyyah Siddiqui
- Department of Biology, Chemistry and Environmental Sciences, College of Arts and Sciences, American University of Sharjah, PO Box 26666, University City, Sharjah, United Arab Emirates
| | - Naveed Ahmed Khan
- Department of Biology, Chemistry and Environmental Sciences, College of Arts and Sciences, American University of Sharjah, PO Box 26666, University City, Sharjah, United Arab Emirates
| |
Collapse
|
2
|
Jackson S, Meeks C, Vézina A, Robey RW, Tanner K, Gottesman MM. Model systems for studying the blood-brain barrier: Applications and challenges. Biomaterials 2019; 214:119217. [PMID: 31146177 DOI: 10.1016/j.biomaterials.2019.05.028] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2018] [Revised: 05/13/2019] [Accepted: 05/16/2019] [Indexed: 12/21/2022]
Abstract
The blood-brain barrier (BBB) poses a serious impediment to the delivery of effective therapies to the central nervous system (CNS). Over time, various model systems have been crafted and used to evaluate the complexities of the BBB, which includes an impermeable physical barrier and a series of energy-dependent efflux pumps. Models of the BBB have mainly sought to assess changes in endothelial cell permeability, the role of ATP-dependent efflux transporters in drug disposition, and alterations in communication between BBB cells and the microenvironment. In the context of disease, various animal models have been utilized to examine real time BBB drug permeability, CNS dynamic changes, and overall treatment response. In this review, we outline the use of these in vitro and in vivo blood-brain barrier model systems to study normal physiology and diseased states. These current models each have their own advantages and disadvantages for studying the response of biologic processes to physiological and pathological conditions. Additional models are needed to mimic more closely the dynamic quality of the BBB, with the goal focused on potential clinical applications.
Collapse
Affiliation(s)
- Sadhana Jackson
- Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.
| | - Caitlin Meeks
- Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States
| | - Amélie Vézina
- Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States
| | - Robert W Robey
- Multidrug Resistance Section, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States
| | - Kandice Tanner
- Tissue Morphodynamics Unit, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States
| | - Michael M Gottesman
- Multidrug Resistance Section, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, United States
| |
Collapse
|
3
|
Krappmann S. Lightning up the worm: How to probe fungal virulence in an alternative mini-host by bioluminescence. Virulence 2015; 6:727-9. [PMID: 26537579 PMCID: PMC4826133 DOI: 10.1080/21505594.2015.1103428] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022] Open
Affiliation(s)
- Sven Krappmann
- a Mikrobiologisches Institut - Klinische Mikrobiologie; Immunologie und Hygiene; Universitätsklinikum Erlangen; Friedrich-Alexander-Universität Erlangen-Nürnberg ; Erlangen , Germany.,b Medical Immunology Campus Erlangen; Friedrich-Alexander University Erlangen-Nürnberg ; Erlangen , Germany
| |
Collapse
|
4
|
El Khoury J. The blood-brain barrier and pathogens: Hadrian's Wall or a Dardanian gate? Virulence 2012; 3:157-8. [PMID: 22460634 DOI: 10.4161/viru.19751] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Affiliation(s)
- Joseph El Khoury
- NeuroImmunology Laboratory, Center for Immunology & Inflammatory Diseases, Division of Infectious Diseases, Massachusetts General Hospital, Charlestown, MA, USA.
| |
Collapse
|